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Abstract
Introduction: Hyperkalemia is rare in individuals with normal renal function, regardless of dietary intake. This is
due to the ability of the kidneys to adapt to increasing serum potassium concentrations. In patients with renal
compromise, potassium homeostasis can become impaired. Palmaria palmata (dulse) is an edible seaweed known
to be very rich in potassium. We report a case of hyperkalemia precipitated by the consumption of dulse by a
patient with known renal disease.
Case Presentation: A 66-year-old Caucasian woman with diabetes and chronic renal disease presented to our
emergency department with nausea, vomiting, and worsening malaise, which had been present for less than a
day. She had undergone electrocardiogram monitoring, which showed bradycardia, and periods of asystole. Our
patient denied any other symptoms. Laboratory analysis revealed a serum potassium level of 8.6 mmol/L (normal
range 3.5 to 4.9 mmol/L). Although our patient was taking some medications known to influence renal function,
the only recent change that she could recount was that she had consumed approximately 200 g of dulse within
the preceding 24 hours. A diagnosis of hyperkalemia was made, and the patient was treated successfully, and
discharged home in her pre-morbid state.
Conclusion: To the best of our knowledge, this is the first published report of hyperkalemia due to dulse
consumption. Dulse is high in potassium, with concentrations upwards of 34 times greater than that found in
bananas. Caution should be taken in prescribing medications with potential adverse renal effects for patients with
known renal impairment. In such instances, renal function should be monitored closely. Patients should be
counseled to avoid dietary sources high in potassium, with particular attention paid to unusual geographical
dietary variations.
Introduction
Hyperkalemia is rare in individuals with normal renal
function, regardless of dietary intake. This is due to the
ability of the kidneys to adapt to increasing serum
potassium concentrations. In patients with renal impair-
ment, potassium homeostasis can become impaired. Pal-
maria palmata (dulse) is an edible seaweed known to be
very rich in potassium. We describe a case of hyperkale-
mia precipitated by the consumption of dulse in a
patient with known renal disease.
Case Presentation
A 66-year-old, non-smoking Caucasian woman was
transferred to our emergency department after she had
presented to a community health clinic with nausea,
vomiting, and worsening malaise that had been present
for less than a day. An electrocardiogram (EKG) per-
formed at the clinic showed bradycardia, and periods of
asystole. Our patient denied any other symptoms,
including chest pain, shortness of breath, and syncope.
The only recent change that she could recount was that
she had consumed approximately 200 g of dulse the
previous day (Figure 1).
Our patient’s medical history included type 2 diabetes
mellitus, hypertension, hypercholesterolemia, gout, anxi-
ety, and chronic renal disease. Her medications on
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pam, rosuvastatin, ezetimibe, losartan, metformin, piogli-
tazone, amlodipine, acebutolol, famciclovir, nortriptyline,
hydroxyzine, and hydrocortisone acetate cream. None of
the medications were new to the patient.
On physical examination, we found our patient to be
an alert, and oriented, obese woman of stated age, with
a Glasgow coma scale score of 15. Her heart rate was
irregularly irregular, and bradycardic at 30 beats per
minute, blood pressure was 124/82 mmHg, and respira-
tions were tachypnic at 28 breaths per minute, with an
oxygen saturation of 98% on 100% oxygen administered
by facemask. The remainder of the physical examination
was unremarkable.
Laboratory investigation revealed an elevated white
blood cell count, normal hemoglobin, normal platelets,
and a random glucose level of 10.2 mmol/L (reference
range 3.0 to 6.0 mmol/L). Testing for cardiac enzymes
was negative. Arterial blood gas revealed a compensated
respiratory alkalosis, with a pH of 7.40, PaCO2 of 33
mmHg, PaO2 of 80 mmHg, and a HCO3 of 21 mEq/L.
Renal function was impaired, with elevated serum urea
(11.9 mmol/L; normal range 2.5 to 7.5 mmol/L), and
creatinine (168 μmol/L; 60 to 110 μmol/L). Estimation
of the patient’s glomerular filtration rate revealed a crea-
tinine clearance (CrCl) rate of 37 ml/min (normal range
88 to 128 ml/min), which placed her chronic kidney dis-
ease at stage 3b by the National Kidney Foundation cri-
teria [1]. Our patient was also found to be severely
hyperkalemic, with a serum potassium concentration of
8.6 mmol/L (normal range 3.5 to 4.9 mmol/L). Her
EKG rhythm on presentation to the emergency depart-
ment showed an irregularly irregular bradycardic rhythm
with periods of asystole, absent P waves, widened QRS
complex, and peaked t waves (Figure 2).
We diagnosed our patient with hyperkalemia second-
ary to acute on chronic renal failure, precipitated by the
consumption of a large amount of potassium-rich dulse.
She was admitted to the intensive care unit, and started
on a treatment regimen that included insulin, bicarbo-
nate, calcium gluconate, and sodium polystyrene sulfo-
nate (Kayexalate - Sanofi-Aventis, Laval, Quebec,
Canada). Our patient’s usual doses of allopurinol, met-
formin, and losartan were withdrawn, and ultimately
discontinued.
Our patient showed marked improvement overnight,
and was discharged to the ward. Within a few hours of
treatment initiation, her serum potassium had almost
completely normalized (5.5 mmol/L), as did the EKG
changes (Figure 2A, and 2B). By the next morning, she
was eukalemic (4.1 mmol/L), with a normal sinus
rhythm (Figure 2C). Her serum creatinine level also
improved, and at discharge was close to the patient’s
pre-admission baseline (93 μmol/L), with an estimated
CrCl of 66 ml/min, indicating stage 2 chronic kidney
disease [1]. She remained stable with a normal potas-
sium, and cardiac rhythm, and was discharged on hospi-
tal day seven (Figure 2D).
Discussion
Dulse, the colloquial name given to Palmaria palmata,
is a common red seaweed, inhabiting the rocky marine
coastline, and tidepools [2]. It is named because of its
resemblance to the palmar surface of the hand (Latin,
palma). The use of dulse can be dated back to the 12th
century in Ireland. Although it can be consumed
directly after harvesting, it is most often served sun-
dried. In the Maritime Provinces of eastern Canada,
dulse is widely available, and consumed as a snack food
[ 3 ] .H o w e v e r ,t h e r ea r ef e wa v a i l a b l ed a t ao ni t sc o n -
sumption patterns. Dulse is known to be high in
Figure 1 Dried seaweed (dulse) consumed as a snack food.
Dulse is packaged in brown paper bags (28 cm high by 13.5 cm
wide by 9 cm deep) that have a volume of 3400 cm
3, and are sold
based on weight.
Figure 2 (A-E) EKG changes from initial presentation, and after
treatment initiation. EKG tracing from lead II at (A) initial
presentation, (B) about one hour after initial presentation, (C) about
three hours after initial presentation, (D) about 13 hours after initial
presentation, and (E) at discharge.
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22.2 to 122 mg/g of dry weight [4]. By comparison,
bananas (Musa acuminata colla), a well-known dietary
source of potassium, have a reported potassium content
of around 3.58 mg/g of edible portion [5,6]. To put this
into perspective, the 200 g of dulse consumed by the
patient is equivalent (in terms of weight) to approxi-
mately two peeled bananas, but contains upwards of 34
times the concentration of potassium. The average
daily dietary intake of potassium is between 1550 and
4700 mg, over 90% of which is absorbed via the gastro-
intestinal tract [7].
Hyperkalemia is seldom seen in well individuals with
normal renal function, regardless of dietary intake. The
vast majority (90%) of the daily intake of potassium is
excreted in urine, with the remaining 10% excreted in
stool. This makes renal function essential for effective
potassium management. Hyperkalemia can result from
any one or a combination of all three mechanisms: (1) a
shift in potassium concentration from the intracellular
environment to the extracellular fluid, (2) an increase in
dietary potassium intake, and/or (3) impairment in renal
potassium excretion [7]. It is our contention that
although this patient was predisposed to developing
hyperkalemia by her illness, and medications, its precipi-
tation was triggered by the high potassium load
obtained from the dulse. In this way, her illness, and
medications were necessary for the hyperkalemia, but
not in, and of themselves causative.
Treatment of hyperkalemia involves correcting the
underlying pathology, protecting cardiac tissue from
the toxic effects of potassium, shifting potassium from
the extracellular to the intracellular compartment, and
ultimately increasing potassium excretion [8-11].
Conclusion
To the best of our knowledge, this is the first published
report of hyperkalemia secondary to dulse consumption.
Patients with known renal impairment should be cau-
tiously prescribed medications with potential adverse
renal effects. In such instances where such medications
are necessary, renal function should be monitored clo-
sely. Moreover, patients should be counseled to avoid
dietary sources high in potassium, with particular atten-
tion paid to unusual geographical dietary variations.
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